Maraviroc as Intensification Strategy in HIV-1 Positive Patients with Deficient Immunological Response: an Italian Randomized Clinical TrialStefano Rusconi, Giulia Marchetti, Gabriella d’Ettorre et al.|PLoS ONE|2013Cited by 42
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trialMassimiliano Fabbiani, Roberta Gagliardini, Nicoletta Ciccarelli et al.|Journal of Antimicrobial Chemotherapy|2018Cited by 33
Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection–Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective StudyAntonio Muscatello, Alessandra Bandera, Silvia Nozza et al.|Pathogens and Immunity|2020Cited by 25
Timed Short Messaging Service Improves Adherence and Virological Outcomes in HIV-1–Infected Patients With Suboptimal Adherence to Antiretroviral TherapyAdriana Ammassari, Andrea Antinori, Maria Paola Trotta et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2011Cited by 25
Prevalence and predictors of long corrected QT interval in HIV-positive patientsSebastiano Gili, Fiorenzo Gaïta, Massimo Mancone et al.|Journal of Cardiovascular Medicine|2016Cited by 23